Pfizer LITFULO Vitiligo Phase 3 Results: Ritlecitinib Improves Facial and Total Body Repigmentation at EADV
Pfizer LITFULO vitiligo Phase 3 results from TRANQUILLO 2 and TRANQUILLO show significant facial and total body repigmentation versus placebo at Week 52, supporting planned FDA and EMA submissions.
